87 related articles for article (PubMed ID: 17621266)
1. Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells.
Chang TW; Chen CC; Chen KY; Su JH; Chang JH; Chang MC
Oncogene; 2008 Jan; 27(3):332-8. PubMed ID: 17621266
[TBL] [Abstract][Full Text] [Related]
2. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.
Ma W; Stafford LJ; Li D; Luo J; Li X; Ning G; Liu M
J Cell Biochem; 2007 Apr; 100(6):1376-86. PubMed ID: 17131381
[TBL] [Abstract][Full Text] [Related]
3. A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment.
Lee I; Yeom SY; Lee SJ; Kang WK; Park C
Cancer Res; 2010 Jun; 70(11):4357-65. PubMed ID: 20460530
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of GCIP in breast carcinoma: relationship with tumour grade, disease-free survival, mucinous differentiation and response to chemotherapy.
Chen WC; Su PF; Jin YT; Chang MC; Chang TW
Histopathology; 2008 Nov; 53(5):554-60. PubMed ID: 18983464
[TBL] [Abstract][Full Text] [Related]
5. Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis.
Ma W; Xia X; Stafford LJ; Yu C; Wang F; LeSage G; Liu M
Oncogene; 2006 Jul; 25(30):4207-16. PubMed ID: 16501603
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of ribosomal protein P0 is not essential for ribosome function but can affect translation.
Rodriguez-Gabriel MA; Remacha M; Ballesta JP
Biochemistry; 1998 Nov; 37(47):16620-6. PubMed ID: 9843429
[TBL] [Abstract][Full Text] [Related]
7. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
9. The acidic protein binding site is partially hidden in the free Saccharomyces cerevisiae ribosomal stalk protein P0.
Pérez-Fernández J; Remacha M; Ballesta JP
Biochemistry; 2005 Apr; 44(14):5532-40. PubMed ID: 15807547
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice.
Marzocchella L; Sini V; Buonomo O; Orlandi A; Masuelli L; Bonanno E; Lista F; Turriziani M; Manzari V; Roselli M; Modesti A; Bei R
Cancer Sci; 2011 Mar; 102(3):509-15. PubMed ID: 21175994
[TBL] [Abstract][Full Text] [Related]
11. Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma.
Barnard GF; Staniunas RJ; Mori M; Puder M; Jessup MJ; Steele GD; Chen LB
Cancer Res; 1993 Sep; 53(17):4048-52. PubMed ID: 8395335
[TBL] [Abstract][Full Text] [Related]
12. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer.
Wu G; Guo Z; Chatterjee A; Huang X; Rubin E; Wu F; Mambo E; Chang X; Osada M; Sook Kim M; Moon C; Califano JA; Ratovitski EA; Gollin SM; Sukumar S; Sidransky D; Trink B
Cancer Res; 2006 Oct; 66(20):9829-36. PubMed ID: 17047043
[TBL] [Abstract][Full Text] [Related]
14. The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomas.
Bei R; Masuelli L; Trono P; Orvietani PL; Losito S; Marzocchella L; Vitolo D; Albonici L; Mrozek MA; Di Gennaro E; Lista F; Faggioni G; Ionna F; Binaglia L; Manzari V; Budillon A; Modesti A
Int J Oncol; 2007 Dec; 31(6):1301-8. PubMed ID: 17982655
[TBL] [Abstract][Full Text] [Related]
15. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
Montano X
Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of human ARIP2 and its relation to breast cancer.
Li ZD; Wu Y; Bao YL; Yu CL; Guan LL; Wang YZ; Meng XY; Li YX
Cytokine; 2009 May; 46(2):251-9. PubMed ID: 19349195
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the 26S rRNA-binding domain in Saccharomyces cerevisiae ribosomal stalk phosphoprotein P0.
Santos C; Ballesta JP
Mol Microbiol; 2005 Oct; 58(1):217-26. PubMed ID: 16164560
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of p53 by its antisense in MCF-7 breast carcinoma cells increases cyclin D1 via activation of Akt and promotion of cell proliferation.
Chhipa RR; Kumari R; Upadhyay AK; Bhat MK
Exp Cell Res; 2007 Nov; 313(19):3945-58. PubMed ID: 17935714
[TBL] [Abstract][Full Text] [Related]
20. Dip1 inhibits growth and gene transcription in MCF-7 breast cancer cells.
Su T; Deguchi A; Yao Y; Luo J; Weinstein IB
J Exp Ther Oncol; 2007; 6(2):117-27. PubMed ID: 17407970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
